Malin Lemurell

901 total citations
15 papers, 587 citations indexed

About

Malin Lemurell is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Malin Lemurell has authored 15 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Malin Lemurell's work include Chemical Synthesis and Analysis (3 papers), RNA Interference and Gene Delivery (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Malin Lemurell is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), RNA Interference and Gene Delivery (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Malin Lemurell collaborates with scholars based in Sweden, Netherlands and United Kingdom. Malin Lemurell's co-authors include Eric Valeur, Alleyn T. Plowright, Tom N. Grossmann, Herbert Waldmann, Stéphanie M. Guéret, Hélène Adihou, R. Gopalakrishnan, Laurent Knerr, Daniel Abegg and Alexander Adibekian and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Malin Lemurell

15 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malin Lemurell Sweden 12 402 184 60 49 48 15 587
Hiroyuki Kakinuma Japan 14 325 0.8× 288 1.6× 45 0.8× 65 1.3× 83 1.7× 43 744
Jeremy Davis United Kingdom 13 497 1.2× 279 1.5× 115 1.9× 90 1.8× 57 1.2× 24 796
Norbert Furtmann Germany 16 337 0.8× 325 1.8× 97 1.6× 111 2.3× 142 3.0× 31 701
Monish Jain United States 9 181 0.5× 169 0.9× 27 0.5× 60 1.2× 35 0.7× 17 525
Andrei W. Konradi United States 14 298 0.7× 328 1.8× 37 0.6× 63 1.3× 24 0.5× 27 754
Timothy B. Durham United States 15 232 0.6× 248 1.3× 88 1.5× 28 0.6× 57 1.2× 21 518
Douglas G. Batt United States 18 274 0.7× 405 2.2× 105 1.8× 92 1.9× 26 0.5× 35 803
James E. Sheppeck United States 15 313 0.8× 296 1.6× 72 1.2× 72 1.5× 24 0.5× 24 628
Hitoshi Sakashita Japan 10 220 0.5× 80 0.4× 30 0.5× 50 1.0× 54 1.1× 19 409
Masahiro Kamaura Japan 13 264 0.7× 156 0.8× 23 0.4× 71 1.4× 20 0.4× 20 472

Countries citing papers authored by Malin Lemurell

Since Specialization
Citations

This map shows the geographic impact of Malin Lemurell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Lemurell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Lemurell more than expected).

Fields of papers citing papers by Malin Lemurell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malin Lemurell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Lemurell. The network helps show where Malin Lemurell may publish in the future.

Co-authorship network of co-authors of Malin Lemurell

This figure shows the co-authorship network connecting the top 25 collaborators of Malin Lemurell. A scholar is included among the top collaborators of Malin Lemurell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malin Lemurell. Malin Lemurell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rácz, Anita, Maximilian Beckers, Nikolas Fechner, et al.. (2025). The changing landscape of medicinal chemistry optimization. Nature Reviews Drug Discovery. 24(11). 870–887. 3 indexed citations
2.
Nilsson, Jesper R., Audrey Gallud, Malin Lemurell, et al.. (2024). Metabolic RNA labeling in non-engineered cells following spontaneous uptake of fluorescent nucleoside phosphate analogues. Nucleic Acids Research. 52(17). 10102–10118. 3 indexed citations
3.
Haniff, Hafeez S., Xiaohui Liu, Yuquan Tong, et al.. (2021). A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype. Cell chemical biology. 29(2). 300–311.e10. 24 indexed citations
4.
Nilsson, Jesper R., Fredrik Edfeldt, Anders Dahlén, et al.. (2021). Interbase-FRET binding assay for pre-microRNAs. Scientific Reports. 11(1). 9396–9396. 9 indexed citations
5.
Nilsson, Jesper R., Audrey Gallud, Malin Lemurell, et al.. (2021). Fluorescent base analogues in gapmers enable stealth labeling of antisense oligonucleotide therapeutics. Scientific Reports. 11(1). 11365–11365. 11 indexed citations
6.
Haniff, Hafeez S., Laurent Knerr, Xiaohui Liu, et al.. (2020). Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold–small molecule interactions. Nature Chemistry. 12(10). 952–961. 47 indexed citations
7.
Guéret, Stéphanie M., Rodrigo J. Carbajo, Marco Potowski, et al.. (2020). Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments. Journal of the American Chemical Society. 142(10). 4904–4915. 35 indexed citations
8.
Pettersen, Daniel, Johan Broddefalk, Hans Emtenäs, et al.. (2019). Discovery and Early Clinical Development of an Inhibitor of 5-Lipoxygenase Activating Protein (AZD5718) for Treatment of Coronary Artery Disease. Journal of Medicinal Chemistry. 62(9). 4312–4324. 31 indexed citations
9.
Lemurell, Malin, Johan Ulander, Hans Emtenäs, et al.. (2019). Novel Chemical Series of 5-Lipoxygenase-Activating Protein Inhibitors for Treatment of Coronary Artery Disease. Journal of Medicinal Chemistry. 62(9). 4325–4349. 11 indexed citations
10.
Valeur, Eric, Stéphanie M. Guéret, Hélène Adihou, et al.. (2017). Neue Modalitäten für schwierige Zielstrukturen in der Wirkstoffentwicklung. Angewandte Chemie. 129(35). 10428–10459. 37 indexed citations
11.
Valeur, Eric, Stéphanie M. Guéret, Hélène Adihou, et al.. (2017). New Modalities for Challenging Targets in Drug Discovery. Angewandte Chemie International Edition. 56(35). 10294–10323. 290 indexed citations
12.
Valeur, Eric, et al.. (2016). Targeted delivery for regenerative medicines: an untapped opportunity for drug conjugates. Drug Discovery Today. 22(6). 841–847. 12 indexed citations
13.
Lemurell, Malin, Johan Ulander, Susanne Winiwarter, et al.. (2014). Discovery of AZD6642, an Inhibitor of 5-Lipoxygenase Activating Protein (FLAP) for the Treatment of Inflammatory Diseases. Journal of Medicinal Chemistry. 58(2). 897–911. 35 indexed citations
14.
Buckett, Linda K., Öjvind Davidsson, Hans Emtenäs, et al.. (2013). Identification and design of a novel series of MGAT2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(9). 2721–2726. 25 indexed citations
15.
Boyd, Derek R., Narain D. Sharma, John F. Malone, et al.. (2002). Enzyme-catalysed oxygenation and deoxygenation routes to chiral thiosulfinates. Chemical Communications. 1452–1453. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026